Phase III trial of high-dose cyclophosphamide in patients with multiple sclerosis
Phase of Trial: Phase III
Latest Information Update: 09 May 2012
At a glance
- Drugs Cyclophosphamide (Primary)
- Indications Multiple sclerosis
- Focus Registrational; Therapeutic Use
- Sponsors Accentia Biopharmaceuticals
- 09 May 2012 Plans for this trial presented to potential investigators, according to an Accentia Biopharmaceuticals media release.
- 02 Aug 2007 New trial record.